RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Nature killer cell for solid tumors: Current obstacles and prospective remedies in NK cell therapy and beyond.
Nature killer cell for solid tumors: Current obstacles and prospective remedies in NK cell therapy and beyond.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
近年来,免疫治疗之后,细胞疗法已成为临床肿瘤管理中的一种创新治疗方法。其中,自然杀伤(NK)细胞疗法在血液系统肿瘤治疗方面取得了重大突破。然而,NK细胞治疗实体瘤的疗效仍面临挑战。随着基因编辑和培养技术的发展及其在NK细胞工程化中的应用,NK细胞疗法有望彻底改变实体瘤治疗。本综述探讨NK细胞的发现和生物学特性、其在肿瘤微环境中的作用,以及NK细胞治疗实体瘤的策略、临床试验、挑战和前景。
In recent years, cell therapy has emerged as an innovative treatment method for the management of clinical tumors following immunotherapy. Among them, Natural killer (NK) cell therapy has achieved a significant breakthrough in the treatment of hematological tumors.
However, the therapeutic effectiveness of NK cells in the treatment of solid tumors remains challenging. With the progress of gene editing and culture techniques and their application to NK cell engineering, it is expected that NK cell therapy will revolutionize the treatment of solid tumors. In this review, we explore the discovery and biological properties of NK cells, their role in the tumor microenvironment, and the therapeutic strategies, clinical trials, challenges, and prospects of NK cells in the treatment of solid tumors.
MEMBER ACCOUNT
登录成功会直接打开下一页。